LinkedOmics: analyzing multi-omics data within and across 32 cancer types

Abstract The LinkedOmics database contains multi-omics data and clinical data for 32 cancer types and a total of 11 158 patients from The Cancer Genome Atlas (TCGA) project. It is also the first multi-omics database that integrates mass spectrometry (MS)-based global proteomics data generated by the Clinical Proteomic Tumor Analysis Consortium (CPTAC) on selected TCGA tumor samples. In total, LinkedOmics has more than a billion data points. To allow comprehensive analysis of these data, we developed three analysis modules in the LinkedOmics web application. The LinkFinder module allows flexible exploration of associations between a molecular or clinical attribute of interest and all other attributes, providing the opportunity to analyze and visualize associations between billions of attribute pairs for each cancer cohort. The LinkCompare module enables easy comparison of the associations identified by LinkFinder, which is particularly useful in multi-omics and pan-cancer analyses. The LinkInterpreter module transforms identified associations into biological understanding through pathway and network analysis. Using five case studies, we demonstrate that LinkedOmics provides a unique platform for biologists and clinicians to access, analyze and compare cancer multi-omics data within and across tumor types. LinkedOmics is freely available at http://www.linkedomics.org.

[1]  Mary Goldman,et al.  The UCSC cancer genomics browser: update 2011 , 2010, Nucleic Acids Res..

[2]  Dong-Sup Lee,et al.  Transglutaminase 2 facilitates the distant hematogenous metastasis of breast cancer by modulating interleukin-6 in cancer cells , 2011, Breast Cancer Research.

[3]  The Cancer Genome Atlas Research Network,et al.  Comprehensive molecular characterization of urothelial bladder carcinoma , 2014, Nature.

[4]  Jing Wang,et al.  WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit , 2017, Nucleic Acids Res..

[5]  Jing Cai,et al.  Cancer : A Meta-Analysis The Role of the PTEN / PI 3 K / Akt Pathway on Prognosis in Epithelial Ovarian , 2014 .

[6]  Jun Li,et al.  TCPA: a resource for cancer functional proteomics data , 2013, Nature Methods.

[7]  Junji Tanaka,et al.  Histone deacetylase inhibitor panobinostat induces calcineurin degradation in multiple myeloma. , 2016, JCI insight.

[8]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of urothelial bladder carcinoma , 2014, Nature.

[9]  Jeffrey R. Whiteaker,et al.  Proteogenomic characterization of human colon and rectal cancer , 2014, Nature.

[10]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[11]  D. Goodrich,et al.  The retinoblastoma tumor-suppressor gene, the exception that proves the rule , 2006, Oncogene.

[12]  Benjamin Haibe-Kains,et al.  The molecular basis of breast cancer pathological phenotypes , 2017, The Journal of pathology.

[13]  Hitoshi Tsuda,et al.  Actinin-4 gene amplification in ovarian cancer: a candidate oncogene associated with poor patient prognosis and tumor chemoresistance , 2009, Modern Pathology.

[14]  R. Hanka The Handbook of Research Synthesis , 1994 .

[15]  Mary Goldman,et al.  The UCSC Cancer Genomics Browser: update 2015 , 2014, Nucleic Acids Res..

[16]  Shibing Deng,et al.  OASIS: web-based platform for exploring cancer multi-omics data , 2015, Nature Methods.

[17]  T. Machida,et al.  Expression ratio of CCND1 to CDKN2A mRNA predicts RB1 status of cultured cancer cell lines and clinical tumor samples , 2011, Molecular Cancer.

[18]  Ronald J. Moore,et al.  Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer , 2016, Cell.

[19]  A. Butte,et al.  Systematic pan-cancer analysis of tumour purity , 2015, Nature Communications.

[20]  Min Zhao,et al.  dbEMT: an epithelial-mesenchymal transition associated gene resource , 2015, Scientific Reports.

[21]  Subha Madhavan,et al.  The CPTAC Data Portal: A Resource for Cancer Proteomics Research. , 2015, Journal of proteome research.